Article Details
Retrieved on: 2022-09-09 17:38:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LUND, Sweden, Sept. 9, 2022 /PRNewswire/ -- The board of directors for Hansa Biopharma AB (publ) has today resolved to issue 850769 new class C ...
Article found on: www.benzinga.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here